Drugs / Sodium Alginate Double Action Chewable Tablets
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01872897 Comparator | Jul → Dec 2013 | gastroesophageal reflux disease | Reckitt Benckiser Healthcare (UK) Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sodium Alginate Double Action Chewable Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01872897 ↗ |